Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00105274 · ClinicalTrials.gov registry record
Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
NCT00105274 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH).
The verdict
NCT00105274 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
Study Summary
Velocardiofacial syndrome, also known as 22q11.2 syndrome or DiGeorge syndrome, has been associated with many features such as a cleft palate, heart defects, and learning, speech and feeding problems. It is caused by the absence of a number of genes on chromosome 22, but the mechanism by which this inborn abnormality causes the clinical problems is not known. In this study by the National Institute of Mental Health and the Office of Rare Diseases, we are recruiting participants with 22q11.2 syndrome to come for a three-day stay to our main campus in Bethesda, MD, to participate in a study in which we will investigate the genetic makeup of their cells together with several studies of brain function with advanced research imaging. The goal of this study is to understand how the genes missing in 22q11.2 syndrome are related to the increased occurrence of psychiatric problems, such as psychosis, in this syndrome. Participants must be 18-50 years of age, have some high school education and not currently be taking antipsychotic medication. Travel costs to Bethesda for participants and an accompanying person will be paid, and participants are reimbursed for their time in participating in the study. A blood draw is required. All research procedures have been designated as "minimal risk" procedures. ...
Trial Details
| Field | Value |
|---|---|
| Start Date | 2005-03-07 |
| Est. Completion | 2010-02-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00105274
The ClinicalTrials.gov registry entry for NCT00105274 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00105274 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00105274 about?
NCT00105274 is a clinical study titled "Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study". Velocardiofacial syndrome, also known as 22q11.2 syndrome or DiGeorge syndrome, has been associated with many features such as a cleft palate, heart defects, and learning, speech and feeding problems. It is caused by the absence of a number of genes on chromosome 22, but the mechanism by which this ...
What is the current status of trial NCT00105274?
This trial is currently completed. The study started on 2005-03-07. Estimated completion is 2010-02-02.
Who is sponsoring clinical trial NCT00105274?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.